Omeros Corporation
NASDAQOMER short interest hits 17.5% of float, down 18.6% in one month, as Cantor upgrades to Overweight with $22 price target.
OMER enters its August 13 earnings release having rallied 33% in a month, yet the borrow market tells a starkly different story from the price action — the lending pool is effectively exhausted. Availability has…
Short sellers have pushed OMER to a breaking point. Availability has collapsed to 0% — every share in the lending pool is currently lent out. That's not a one-day anomaly. Availability has been at or near zero for most…
Snapshot as of 27 Sept 2026
OMER heads into its June 18 earnings report with the lending pool completely dry and short sellers holding near a quarter of the float. The borrow picture is the sharpest signal this week. Availability has collapsed to…
Omeros Corporation heads into its May 14 earnings report with the lending market for its shares as tight as it has ever been — a setup that makes the short side of this stock unusually constrained. The borrow squeeze…
Omeros Corporation enters its Q1 2026 earnings release — due after the close on May 14 — in a state of genuine short-selling pressure, with one of the tightest borrow markets in the small-cap pharma space and a short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OMER — free to start on ORTEX.
Sign up for free →Open OMER on ORTEX